Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay

AIDS Research and Human Retroviruses

Volumn 22, Issue 10, 2006, Pages 945-952

  McDougal, J Steven ^a,c   Parekh, Bharat S ^a   Peterson, Michael L ^b   Branson, Bernard M ^a   Dobbs, Trudy ^a   Ackers, Marta ^a   Gurwith, Marc ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b VaxGen Inc   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLACEBO;

ANALYTICAL ERROR; ARTICLE; BED CAPTURE ENZYME IMMUNOASSAY; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; ENZYME IMMUNOASSAY; EVALUATION; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEROCONVERSION;

ALGORITHMS; CLINICAL TRIALS, PHASE III; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; INCIDENCE; MALE;

EID: 33846195892     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.945     Document Type: Article

References (24)

1. McDougal JS, Pilcher CD, Parekh BS, Gershy-Damet G, Branson BM, Marsh K, and Wiktor SZ: Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries. AIDS 2005;19:S25-S30.
2. Cleghorn FR, Jack N, Murphy JR, Edwards J, Mahabir B, Paul R, O'Brien T, Greenberg M, Weinhold K, Bartholomew C, Brookmeyer R, and Blattner WA: Direct and indirect estimates of HIV-1 incidence in a high-prevalence population. Am J Epidemiol 1998;147:834-839.
3. Gouws E, Williams BG, Sheppard HW, Enge B, and Karim SA: High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion. J Acquir Immune Defic Syndr 2002;29:531-535.
4. Kellogg TA, Loeb L, Dilley J, Adler B, Briant L, and McFarland W: Comparison of three methods to measure HIV incidence among persons seeking voluntary, anonymous counseling and testing. J Acquir Immune Defic Syndr 2005;39:112-120.
5. McFarland W, Kellogg TA, Louie B, Murrill C, and Katz MH: Low estimates of HIV seroconversions among clients of a drug treatment clinic in San Francisco, 1995 to 1998. J Acquir Immune Defic Syndr 2000;23:426-429.
6. Calzavara L, Burchell AN, Major C, Remis RS, Corey L, Myers T, Millson P, Wallace E, and Polaris Study Team: Increases in HIV incidence among men who have sex with men undergoing repeat diagnostic HIV testing in Ontario, Canada. AIDS 2002;16: 1655-1661.
7. Parekh BS, Pau CP, Kennedy MS, Dobbs TL, and McDougal JS: Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection. AIDS Res Hum Retroviruses 2001;17:137-146.
8. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, Hu DJ, Vanichseni S, Young NL, Choopanya K, Mastro TD, and McDougal JS: Quantitative detection of increasing HIV type 1 antibodies after seroconversion: A simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002;18:295-307.
9. Constantine JT, Sill AM, Jack N, Kreisel K, Edwards J, Cafarella T, Smith H, Bartholomew C, Cleghorn FR, and Blattner WA: Improved classification of recent HIV-1 infection by employing a two-stage sensitive/less-sensitive test strategy. J Acquir Immune Defic Syndr 2003;32:94-103.
10. Kothe D, Byers R, Caudill SP, Satten GA, Janssen RS, Hannon WH, and Mei JV: Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 2003;33:625-634.
11. Rawal BD, Degula A, Lebedeva L, Janssen RS, Hecht FM, Sheppard HW, and Busch MP: Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J Acquir Immune Defic Syndr 2003;33:349-355.
12. Murphy D, Charlett A, Osner N, Gill ON, and Parry JV: Reconciling HIV incidence results from two assays employed in the serological testing algorithm for recent HIV seroconversion (STARHS). J Virol Methods 2003;113:79-86.
13. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, and Busch MP: New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998;280:42-48.
14. Quinn TC, Brookmeyer R, Kline R, Shepherd M, Paranjape R, Mehendale S, Gadkari DA, and Bollinger R: Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS 2000;14:2751-2757.
15. Brookmeyer R, Quinn T, Shepherd M, Mehendale S, Rodrigues J, and Bollinger R: The AIDS epidemic in India: A new method for estimating current human immunodeficiency virus incidence rates. Am J Epidemiol 1995;142:709-713.
16. Beyrer C, Brookmeyer R, Natpratan C, Kunawararak P, Niraroot V, Palapunya P, Khamboonruang C, Celentano DD, and Nelson KE: Measuring HIV-1 incidence in northern Thailand: Prospective cohort results and estimates based on early diagnostic tests. J Acquir Immune Defic Syndr 1996;12:495-499.
17. Hu DJ, Vanichseni S, Mock PA, Young NL, Dobbs T, Byers R, Choopanya K, Van Griensven F, KitayapomD, McDougal JS, Tappero JW, Mastro TD, and Parekh BS: HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: Use of the IgG capture BED immunoassay. AIDS Res Hum Retroviruses 2003;19:727-730.
18. Dobbs T, Kennedy S, Pau CP, McDougal JS, and Parekh BS: Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 2004;42: 2623-2628.
19. Nesheim S, Parekh BS, Sullivan K, Bulterys M, Dobbs T, Lindsay M, Cashat-Cruz M, Byers B, and Lee F: Temporal trends in HIV type 1 incidence among inner-city childbearing women in Atlanta: Use of the IgG-capture BED-enzyme immunoassay. AIDS Res Hum Retroviruses 2005;21:537-544.
20. Saphonn V, Parekh BS, Dobbs T, Mean C, Bun LH, Ly SP, Heng S, and Detels R: Trends of HIV-1 seroincidence among HIV-1 sentinal surveillance groups in Cambodia, 1999-2002. J Acquir Immune Defic Syndr 2005;39:587-592.
21. The rgp120 HIV Vaccine Study Group: Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis 2005;191:654-665.
22. Byers RH, Hu DJ, and Janssen RS: Estimating HIV incidence from a cross-sectional survey with the less sensitive assay. In: Deterministic and Stochastic Models for AIDS Epidemics (Tan WY and Wu H, eds.). World Scientific Publishers, Hackensack, NJ, 2005, pp. 1-15.
23. Karita E, Manigart O, Stevens G, Allen S, Hunter E, Price M, Fast P, Stevens W, and Ketter N: Investigating the utility of the anti-HIV-1 IgG capture enzyme immunoassay (BED CEIA) to detect early HIV infections using known incident infection panels from Lusaka, Zambia and Kigali, Rwanda. AIDS Vaccine Conference, Montreal, Canada, September 6-9, 2005; abstract 360P.
24. Rehle T, Lazzari S, Dallabetta G, and Asamoah-Odei E: Second-generation HIV surveillance: Better data for decision-making. Bull WHO 2004;82:121-127.